Together, these data support the hypothesis that endogenous levels of mutant PFN1 directly affects the nuclear pore structure/stability in ALS patient cells, possibly leading to neuronal degeneration. This evidence concerns the gene PFN1 and amyotrophic lateral sclerosis.